Thursday, April 26, 2018
5:30pm - 7:30pm EDT
Despite all the noise about algorithms, cryptocurrency, and HFT, investors continue to believe Management is the #1 factor in the success of any business, and, consequently, their investments. And since management's time is limited, and their responsibilities manifold, they have increasingly come to rely upon a qualified Investor Relations Officer to effectively represent them with the investment community.
NIRI Philadelphia is proud to announce that on April 26 we have gathered a distinguished panel of CEO's of local, publicly traded companies who will offer their insight into the critical Management/IRO dynamic. What value is the value of an IRO to the CEO? The company? What are the executive's expectations of their IRO?
Both tenured and new IROs are certain to walk away from this session with fresh ideas on how to increase your value to your CEO and company.
Both tenured and new IROs are certain to walk away from this session with fresh ideas on how to increase your value to your CEO and company.
Panelists: Christopher Franklin, CEO of Aqua America
Christopher Cashman, CEO of Marinus Pharmaceuticals
Stephen Zarrilli, CEO of Safeguard Scientifics
Stephen Zarrilli, CEO of Safeguard Scientifics
